investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Targeted therapy of B cell malignances with CAR-T cells of defined composition

Stanley R. Riddell

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Pier Paolo Pandolfi

Targeting Tumor Suppressive Pathways for Cancer Therapy

Leukaemia

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

A. Thomas Look

Discovery of New Targets and Pathways for T-ALL Therapy

Leukaemia

Eduardo M. Sotomayor

Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy

Non-Hodgkin lymphoma

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia

Hematology and hematologic malignancies Pathology

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Richard John O'Reilly

Immunobiology for Marrow Allografts for Leukemia

Leukaemia

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Non-Hodgkin lymphoma